Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook

Go back to Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook
Merck & Co. (NYSE: MRK) Delayed: 128.66 +3.21 (2.56%)
Previous Close $125.45    52 Week High $65.46 
Open $125.83    52 Week Low $47.97 
Day High $128.78    P/E 87.52 
Day Low $125.83    EPS $1.47 
Volume 18,891,511